These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 30523374)
21. The energy based devices for vaginal "rejuvenation," urinary incontinence, vaginal cosmetic procedures, and other vulvo-vaginal disorders: An international multidisciplinary expert panel opinion. Digesu GA; Tailor V; Preti M; Vieira-Baptista P; Tarcan T; Stockdale C; Mourad S Neurourol Urodyn; 2019 Mar; 38(3):1005-1008. PubMed ID: 30697814 [TBL] [Abstract][Full Text] [Related]
22. [Vaginal laser therapy for urinary incontinence and genitourinary syndrome of menopause : A review]. Ratz C Urologe A; 2019 Mar; 58(3):284-290. PubMed ID: 30721329 [TBL] [Abstract][Full Text] [Related]
23. The urogenital system and the menopause. Calleja-Agius J; Brincat MP Climacteric; 2015; 18 Suppl 1():18-22. PubMed ID: 26366796 [TBL] [Abstract][Full Text] [Related]
24. [Current aspects of the treatment of urogenital atrophy (based on the consensus of britain society of menopause)]. Balan VE; Tikhomirova EV; Tsarkova AV; Gadgieva ZK Urologiia; 2019 Dec; (5):150-154. PubMed ID: 31808652 [TBL] [Abstract][Full Text] [Related]
25. Radiofrequency-Based Devices for Female Genito-Urinary Indications: Position Statements From the European Society of Sexual Medicine. Romero-Otero J; Lauterbach R; Aversa A; Serefoglu EC; García-Gómez B; Parnhan A; Skrodzka M; Krychman M; Reisman Y; Corona G; Lowenstein L J Sex Med; 2020 Mar; 17(3):393-399. PubMed ID: 32129169 [TBL] [Abstract][Full Text] [Related]
26. Genitourinary syndrome of menopause and the use of laser therapy. Hutchinson-Colas J; Segal S Maturitas; 2015 Dec; 82(4):342-5. PubMed ID: 26323234 [TBL] [Abstract][Full Text] [Related]
27. Patient reported vaginal laxity, sexual function and stress incontinence improvement following vaginal rejuvenation with fractional carbon dioxide laser. Toplu G; Serin M; Unveren T; Altinel D J Plast Surg Hand Surg; 2021 Feb; 55(1):25-31. PubMed ID: 33030095 [TBL] [Abstract][Full Text] [Related]
28. Vaginal laser therapy for gynecologic conditions: re-examining the controversy and where do we go from here. Zipper R; Lamvu G J Comp Eff Res; 2022 Aug; 11(11):843-851. PubMed ID: 35726603 [TBL] [Abstract][Full Text] [Related]
29. Laser Therapy for Genitourinary Syndrome of Menopause. Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032 [TBL] [Abstract][Full Text] [Related]
30. The Rationale for Photobiomodulation Therapy of Vaginal Tissue for Treatment of Genitourinary Syndrome of Menopause: An Analysis of Its Mechanism of Action, and Current Clinical Outcomes. Lanzafame RJ; de la Torre S; Leibaschoff GH Photobiomodul Photomed Laser Surg; 2019 Jul; 37(7):395-407. PubMed ID: 31210575 [No Abstract] [Full Text] [Related]
31. A Systematic Review of Nonsurgical Vulvovaginal Restoration Devices: An Evidence-Based Examination of Safety and Efficacy. Preminger BA; Kurtzman JS; Dayan E Plast Reconstr Surg; 2020 Nov; 146(5):552e-564e. PubMed ID: 33141529 [TBL] [Abstract][Full Text] [Related]
32. Device-based treatment for vaginal wellness. Alexiades M Semin Cutan Med Surg; 2018 Dec; 37(4):226-232. PubMed ID: 30475926 [TBL] [Abstract][Full Text] [Related]
33. Vaginal energy-based devices: characterization of adverse events based on the last decade of MAUDE safety reports. Wallace SL; Sokol ER; Enemchukwu EA Menopause; 2020 Sep; 28(2):135-141. PubMed ID: 33003133 [TBL] [Abstract][Full Text] [Related]
34. The complexity of genitourinary syndrome of menopause: number, severity, and frequency of vulvovaginal discomfort symptoms in women enrolled in a randomized trial evaluating treatment for genitourinary syndrome of menopause. Mitchell CM; Larson JC; Reed SD; Guthrie KA Menopause; 2023 Aug; 30(8):791-797. PubMed ID: 37402281 [TBL] [Abstract][Full Text] [Related]
35. Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial. Mackova K; Mazzer AM; Mori Da Cunha M; Hajkova Hympanova L; Urbankova I; Kastelein AW; Vodegel E; Vander Linden K; Fehervary H; Guler Z; Roovers JP; Krofta L; Verhaeghe J; Deprest J BJOG; 2021 May; 128(6):1087-1096. PubMed ID: 33017509 [TBL] [Abstract][Full Text] [Related]
36. New therapeutic option in genitourinary syndrome of menopause: pilot study using microablative fractional radiofrequency. Kamilos MF; Borrelli CL Einstein (Sao Paulo); 2017; 15(4):445-451. PubMed ID: 29364367 [TBL] [Abstract][Full Text] [Related]
37. Laser-Based Devices for Female Genitourinary Indications: Position Statements From the European Society for Sexual Medicine (ESSM). Romero-Otero J; Lauterbach R; Aversa A; Serefoglu EC; García-Gómez B; Parnham A; Skrodzka M; Krychman M; Reisman Y; Corona G; Lowenstein L J Sex Med; 2020 May; 17(5):841-848. PubMed ID: 32201147 [TBL] [Abstract][Full Text] [Related]
38. Vaginal Rejuvenation: A Retrospective Review of Lasers and Radiofrequency Devices. Juhász MLW; Korta DZ; Mesinkovska NA Dermatol Surg; 2021 Apr; 47(4):489-494. PubMed ID: 33165070 [TBL] [Abstract][Full Text] [Related]
39. Hormonal Medications for Genitourinary Syndrome of Menopause. Pinkerton JV; Vaughan MH; Kaunitz AM Clin Obstet Gynecol; 2024 Mar; 67(1):68-78. PubMed ID: 38032827 [TBL] [Abstract][Full Text] [Related]
40. Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society. Portman DJ; Gass ML; Maturitas; 2014 Nov; 79(3):349-54. PubMed ID: 25179577 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]